Loading stock data…
AHG
$2.14-0.05 (-2.28%)
Market ClosedLast close May 1
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Akso Health Group in the Healthcare sector is trading at $2.14. The stock is currently 14% below its 52-week high of $2.50, remaining 25.1% above its 200-day moving average. Technical signals show neutral RSI of 37 and bearish MACD signal, explaining why AHG maintains its current momentum and trend strength. The Whystock Score of 70/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 37) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$2.14
Potential Upside
5%
Whystock Fair Value$2.25
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosme...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.70B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.93
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-68.41%
Volume
Today's trading volume
152,773
Recent News
While Akso Health Group (NASDAQ:AHG) shareholders have made 235% in 3 years, increasing losses might now be front of mind as stock sheds 10% this week
While Akso Health Group ( NASDAQ:AHG ) shareholders are probably generally happy, the stock hasn't had particularly...
Why Akso Health Group (AHG) Faces Uncertainty After Auditor Flags Doubt on Financial Viability
On August 14, 2025, Akso Health Group reported its full-year results, showing sales of US$14.78 million and a net loss of US$134.98 million for the period ended March 31, 2025. In the same filing, the company's auditor expressed doubt about Akso Health Group's ability to continue as a going concern, highlighting material uncertainties about its future financial stability. We'll consider how the auditor's going concern warning and sharply increased net loss reshape Akso Health Group's...